Key result
The provided text describes a journal's peer review and publication workflow and contains no clinical data or findings.
Why the study?
Type 2 diabetes is a leading cause of chronic kidney disease worldwide, creating a need for a comprehensive overview of pharmacological and non-pharmacological management strategies.
Population
Patients with type 2 diabetes mellitus and chronic kidney disease
Design
Review article
Authors
Loading...
Supports multimodal CKD care in T2D; leaves open prospective RCTs for validation.
A comprehensive, individualized approach combining pharmacological and non-pharmacological strategies is essential for preventing and managing chronic kidney disease in patients with type 2 diabetes.
María Isabel Gómez (2023) studied Chronic Kidney Disease in Patients with Type 2 Diabetes. The provided text describes a journal's peer review and publication workflow and contains no clinical data or findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: